logo

The objective of this article is to report outcomes from a multiparametric magnetic resonance imaging‐based active surveillance programme that did not include performing protocol b[...]
This Editorial Comment by Hashim Ahmed discusses re‐thinking active surveillance for the multiparametric magnetic resonance imaging era[...]
This video of the week accompanies the article on Four-year outcomes from a mpMRI active surveillance programme[...]
Letter to the Editor Does the introduction of prostate multiparametric magnetic resonance imaging into the active surveillance protocol for localized prostate cancer improve patien[...]
Every week, the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full art[...]
Multiparametric MRI (mpMRI) has become an important adjunct in the management of localized prostate cancer (PCa), particularly in the active surveillance (AS) setting. Current guid[...]
Abstract: Decisions regarding the primary treatment of prostate cancer depend on several patient‐ and disease‐specific factors. Several international guidelines regarding the prima[...]
Every Week, the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full art[...]
A rapid growth rate has long been known to be a harbinger of aggressive tumour pathology and clinical behaviour of small renal masses (SRMs) 1. However, this association has not be[...]
   Multiple growth periods predict unfavourable pathology in patients with small renal masses Alex Jang , Hiten D. Patel, Mark Riffon, Michael A. Gorin , Alice Semerjian, Mic[...]